tiprankstipranks
Calyxt Inc (CLXT)
NASDAQ:CLXT
US Market

Calyxt (CLXT) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

CLXT Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Calyxt
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CLXT Stock 12 Months Forecast

There Are No Analyst Ratings for CLXT In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CLXT Financial Forecast

No data currently available

CLXT Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

CLXT Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity
$10.00
Hold
-68.25%
Downside
Downgraded
02/01/23
Calyxt downgraded to Hold from Buy at CanaccordCalyxt downgraded to Hold from Buy at Canaccord
H.C. Wainwright
Hold
Reiterated
01/18/23
We believe this merger could provide a meaningful catalyst for the story as the combined entity should have a broader platform to address the evolving needs of the agriculture industry. The press release announcing the merger agreement highlights various near-term catalysts with respect to Cibus including the start of its new trait facility that should support the initial transfer of products to customers towards commercialization. The merger is expected to close in 2Q23, but already has the approval of Calyxt's major shareholder Cellectis (CLLS; not rated); according to the press release, Cellectis owns approximately 49.1% of Calyxt’s shares. We will be tracking developments closely and intend to provide a more meaningful update with greater granularity on the strategic outlook for the company once the deal is closed.

CLXT Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

CLXT Stock Forecast FAQ

What is CLXT’s average 12-month price target, according to analysts?
Currently, no data Available
What is CLXT’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CLXT, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CLXT a Buy, Sell or Hold?
      Currently, no data Available
      What is Calyxt Inc’s price target?
      Currently, no data Available
      What do analysts say about Calyxt Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CLXT?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis